Lipocine Profitability Analysis

LPCN -  USA Stock  

USD 1.13  0.04  3.42%

For Lipocine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lipocine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lipocine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lipocine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lipocine over time as well as its relative position and ranking within its peers. Additionally, see Stocks Correlation.

Lipocine Current Profitability Trends 

 
Refresh
Lipocine Price to Sales Ratio is quite stable at the moment as compared to the past year. The company's current value of Price to Sales Ratio is estimated at 54.97. Sales per Share is expected to rise to 0.005542 this year, although the value of Return on Sales will most likely fall to (68.53) . Income Tax Expense is expected to rise to 248.16 this year, although the value of Accumulated Other Comprehensive Income will most likely fall to (47.15) .

Lipocine Revenues

152,398Share
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lipocine Shares Owned by Insiders vs. Market Capitalization Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Lipocine's current stock value. Our valuation model uses many indicators to compare Lipocine value to that of its competitors to determine the firm's financial worth.
Lipocine is rated second overall in market capitalization category among related companies. It is rated second overall in shares owned by insiders category among related companies . The ratio of Market Capitalization to Shares Owned by Insiders for Lipocine is about  38,342,629 . Lipocine Market Capitalization is quite stable at the moment as compared to the past year. The company's current value of Market Capitalization is estimated at 81.84 Million. Comparative valuation analysis is a catch-all model that can be used if you cannot value Lipocine by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lipocine's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lipocine's earnings, one of the primary drivers of an investment's value.

Lipocine Market Capitalization vs. Competition

Lipocine is rated second overall in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 312.12 Million. Lipocine totals roughly 96.24 Million in market capitalization claiming about 31% of stocks in Biotechnology industry.
Capitalization  Revenue  Workforce  Valuation  Total debt

Lipocine Shares Owned by Insiders vs. Market Capitalization

Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Lipocine 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
96.24 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Lipocine 
Insiders Shares 
 = 
Executives Shares 
Employees 
2.51 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Lipocine Shares Owned by Insiders Comparison

Lipocine is currently under evaluation in shares owned by insiders category among related companies.

Lipocine Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Lipocine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lipocine will eventually generate negative long term returns. The profitability progress is the general direction of Lipocine's change in net profit over the period of time. It can combine multiple indicators of Lipocine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2021
Accumulated Other Comprehensive Income(43.70) (47.15) 
Consolidated Income-21 M-21.5 M
Net Income-21 M-21.5 M
Net Income Common Stock-21 M-21.5 M
Operating Income-18 M-19.4 M
Income Tax Expense 230.00  248.16 
Net Income Per Employee-1.2 M-1.3 M
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. The companys pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase II Clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis TLANDO XR, an oral prodrug of testosterone for once daily dosing, which has completed Phase II clinical trial in hypogonadal men LPCN 1148, an oral prodrug of bioidentical testosterone that has completed phase I clinical trial for the treatment of NASH cirrhosis and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. Lipocine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Lipocine Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Lipocine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lipocine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lipocine's important profitability drivers and their relationship over time.

Lipocine Profitability Trends

Lipocine profitability trend refers to the progression of profit or loss within a business. An upward trend means that Lipocine's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Lipocine's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Lipocine Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Lipocine different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Lipocine in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Lipocine's future profitability.

Use Lipocine in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipocine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will appreciate offsetting losses from the drop in the long position's value.

Lipocine Pair Trading

Lipocine Pair Trading Analysis

Correlation analysis and pair trading evaluation for Lipocine and Mustang Bio. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Lipocine position

In addition to having Lipocine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipping Containers Thematic Idea Now

Shipping Containers
Shipping Containers Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Shipping Containers theme has 24 constituents.
View All  Next Launch Shipping Containers
Additionally, see Stocks Correlation. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
To fully project Lipocine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Lipocine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Lipocine's income statement, its balance sheet, and the statement of cash flows.
Potential Lipocine investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Lipocine investors may work on each financial statement separately, they are all related. The changes in Lipocine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lipocine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.